University of Bath Spin-Out Launches to Enhance Lung Cancer Diagnosis and Treatment
India, April 17 -- Prothea Technologies, a new spin-out company from the Universities of Bath and Edinburgh, has launched with a mission to enable lung cancer biopsy and treatment in a single visit.
The firm has attracted €12M (£10.3M) of investment as it seeks to develop a medical device to quickly diagnose lung cancer lesions using a combined endoscope and image-processing system capable of examining the molecular structure of lung lesions. The team also wants to develop a laser-ablation catheter to treat lesions immediately after diagnosis, reducing time-to-treatment from weeks to minutes, relieving hospital pressures and improving patient outcomes.
Prothea Technologies combines extensive optical-fibre research expertise a...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.